GLASGOW, Scotland — New data from a large international registry of thrombolysis in stroke suggest that tissue plasminogen activator (tPA, alteplase) is safe to use in patients with very severe ...

Although the goal for NIHSS completion rate was not met, we believe the project was successful. The NIHSS has been integrated successfully into standard nursing practice in assessments of acute stroke ...

Endovascular therapy is increasingly used after the administration of intravenous tissue plasminogen activator (t-PA) for patients with moderate-to-severe acute ischemic stroke, but whether a combined ...

Using data from more than 270,000 hospital stroke admissions, scientists have identified how to predict which patients are at greatest risk of dying in the hospital after stroke. Before their study, ...

In certain patients with mild-to-moderate acute ischemic stroke, dual antiplatelet therapy (DAPT) with aspirin and clopidogrel (Plavix) reduced early neurologic deterioration better than aspirin alone ...

Tenecteplase shows no benefit over standard care for 90-day functional recovery in patients with minor ischemic stroke and disabling deficits.